Managing LUPUS

SLE is a complex and challenging disease due to its serological complexity, clinical diversity (different types of disease manifestations) and multiple comorbidities (other associated diseases). Advances in understanding the mechanism and progression (pathophysiology) of lupus have changed the therapeutic landscape of this disease. Several drugs are available and many more are in the pipeline currently. The need of the hour is to strike a balance between early diagnosis, drug efficacy, availability and cost.